Back to ELVN
CITADEL ADVISORS LLC ELVN Position History
Enliven Therapeutics, Inc. • Healthcare
Quarters held
10
Latest value
$3.7M
Q2 2026
Peak value
$101.9M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $61.7M |
| Q1 2026 | $1.4M |
| Q1 2026 | $6.6M |
| Q1 2026 | $3.6M |
| Q2 2026 | $101.9M |
| Q2 2026 | $3.1M |
| Q2 2026 | $3.7M |
| Q2 2026 | $101.9M |
| Q2 2026 | $3.1M |
| Q2 2026 | $3.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $3.7M | 72.0K | — | — |
| Q2 2026 | $3.1M | 61.6K | — | — |
| Q2 2026 | $101.9M | 2.01M | — | — |
| Q2 2026 | $3.7M | 72.0K | — | — |
| Q2 2026 | $3.1M | 61.6K | — | — |
| Q2 2026 | $101.9M | 2.01M | — | — |
| Q1 2026 | $3.6M | 91.5K | — | — |
| Q1 2026 | $6.6M | 169.6K | — | — |
| Q1 2026 | $1.4M | 36.1K | — | — |
| Q1 2026 | $61.7M | 1.57M | — | — |